Prosecution Insights
Last updated: October 25, 2026

Schrödinger Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Schrödinger Inc. is currently managing a portfolio within the Semiconductors, Circuits & Optics technology area. The company has 2 pending office actions distributed across 2 distinct art units. This distribution indicates that the pending matters are not concentrated in a single specialized group but are instead being reviewed by different technical sections of the patent office. Practitioners should prepare for diverse procedural requirements as each art unit may have specific internal guidelines or trends that affect the 2 pending office actions.

The prosecution effort involves 2 distinct examiners, reflecting a situation where each pending matter is assigned to a different official. Among these, NGUYEN, LAM S is identified as the busiest examiner for this portfolio. This individual is currently responsible for 1 pending office action. For a practitioner, this suggests a prosecution landscape where each matter requires engagement with a different examiner. Because the 2 pending office actions are handled by 2 distinct examiners, there is no opportunity to leverage a single examiner's perspective across multiple cases. Strategies must be tailored to the specific preferences of NGUYEN, LAM S and the other assigned official to navigate the 1 pending office action effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LUO, JAMMY NMN 1 — —

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18132936 ACCOUNTING FOR INDUCED FIT EFFECTS LUO, JAMMY NMN —

Top Art Units

Art UnitApps
1686 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18132936 ACCOUNTING FOR INDUCED FIT EFFECTS LUO, JAMMY NMN 1686 §101§103§112 Non-Final OA — Pending Apr 10, 2023

Managing Schrödinger Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Schrödinger Inc. have?

Schrödinger Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Schrödinger Inc. applications?

Jammy Nmn Luo has the most, with 1 of Schrödinger Inc.'s pending office actions.

What technology area are Schrödinger Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month